Methyl 3-(2-methoxyethyl)-4-methyl-2-oxo-6-(3,4,5-trimethoxyphenyl)-1,6-dihydropyrimidine-5-carboxylate
C19H26N2O7 — CID 42914644
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 3-(2-methoxyethyl)-4-methyl-2-oxo-6-(3,4,5-trimethoxyphenyl)-1,6-dihydropyrimidine-5-carboxylate
Methyl 3-(2-methoxyethyl)-4-methyl-2-oxo-6-(3,4,5-trimethoxyphenyl)-1,6-dihydropyrimidine-5-carboxylate (PubChem CID 42914644) has the molecular formula C19H26N2O7 and a molecular weight of 394.42 g/mol. Its IUPAC name is methyl 3-(2-methoxyethyl)-4-methyl-2-oxo-6-(3,4,5-trimethoxyphenyl)-1,6-dihydropyrimidine-5-carboxylate.
Molecular Properties
| Compound Name | Methyl 3-(2-methoxyethyl)-4-methyl-2-oxo-6-(3,4,5-trimethoxyphenyl)-1,6-dihydropyrimidine-5-carboxylate |
|---|---|
| PubChem CID | 42914644 |
| Molecular Formula | C19H26N2O7 |
| Molecular Weight | 394.42 g/mol |
| Exact Mass | 394.17 |
| IUPAC Name | methyl 3-(2-methoxyethyl)-4-methyl-2-oxo-6-(3,4,5-trimethoxyphenyl)-1,6-dihydropyrimidine-5-carboxylate |
| SMILES | COCCN1C(=O)NC(c2cc(OC)c(OC)c(OC)c2)C(C(=O)OC)=C1C |
| InChI | InChI=1S/C19H26N2O7/c1-11-15(18(22)28-6)16(20-19(23)21(11)7-8-24-2)12-9-13(25-3)17(27-5)14(10-12)26-4/h9-10,16H,7-8H2,1-6H3,(H,20,23) |
| InChIKey | DRGDDWIOHAONJX-UHFFFAOYSA-N |
| XLogP | 1.87 |
| TPSA | 95.56 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 394.42 |
| LogP ≤ 5 | 1.87 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 42914644 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.